Lobbying firm

KYM H. KILBOURNE

Government relations, health policy

Filings
9
Clients
2
Total income
$112,500
Lobbyists
1
Years active
2013–2014

Filings counts every document on the register, amendments included. Income is the fees reported to clients, counting the current version of each report once.

Income by year

Fees reported, $ thousands 2013 to 2014

Filings

9 filings, newest first.
Filing Client Income Expenses
3rd Quarter - Termination (No Activity)
3rd Quarter 2014, no activity
SHIRE PHARMACEUTICALS — income — expenses
2nd Quarter - Report
2nd Quarter 2014
SHIRE PHARMACEUTICALS $25,000 income — expenses
1st Quarter - Report
1st Quarter 2014
SHIRE PHARMACEUTICALS $25,000 income — expenses
Registration
1st Quarter 2014
SHIRE PHARMACEUTICALS — income — expenses
1st Quarter - Termination
1st Quarter 2014
VIROPHARMA INCORPORATED $12,500 income — expenses
4th Quarter - Amendment
4th Quarter 2013
VIROPHARMA INCORPORATED $50,000 income — expenses
4th Quarter - Reportreplaced
4th Quarter 2013
VIROPHARMA INCORPORATED $12,500 income — expenses
Registration - Amendment
4th Quarter 2013
VIROPHARMA INCORPORATED — income — expenses
Registration
4th Quarter 2013
VIROPHARMA INCORPORATED — income — expenses

Clients

Everyone this filer has reported for, with the reports filed and the income they disclose.

ClientReportsIncome
SHIRE PHARMACEUTICALS 3 $50,000
VIROPHARMA INCORPORATED 2 $62,500

Lobbyists

Everyone named on this filer's reports, with the government post they most recently disclosed here.

LobbyistCovered position, as disclosed
KYM HOWARTH KILBOURNE —

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

From reports filed under the Lobbying Disclosure Act. A firm reports income from each client; an organisation lobbying for itself reports its own expenses instead. Each figure links to the filing it comes from.